Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers.

    Butler SF, Benoit C, Budman SH, Fernandez KC, McCormick C, Venuti SW, Katz N.

    Harm Reduct J. 2006 Feb 2;3:5.

    PMID:
    16457713
    [PubMed]
    Free PMC Article
    2.

    Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation.

    Butler SF, Black R, Grimes Serrano JM, Folensbee L, Chang A, Katz N.

    Pain Med. 2010 Jan;11(1):81-91. Epub 2009 Nov 25.

    PMID:
    20002324
    [PubMed - indexed for MEDLINE]
    3.

    Relative abuse potential of opioid formulations in Canada: a structured field study.

    Sellers EM, Schuller R, Romach MK, Horbay GL.

    J Opioid Manag. 2006 Jul-Aug;2(4):219-27.

    PMID:
    17319483
    [PubMed - indexed for MEDLINE]
    4.

    Measuring attractiveness for abuse of prescription opioids.

    Butler SF, Fernandez KC, Chang A, Benoit C, Morey LC, Black R, Katz N.

    Pain Med. 2010 Jan;11(1):67-80. Epub 2009 Nov 25.

    PMID:
    20002325
    [PubMed - indexed for MEDLINE]
    5.

    Development of an instrument measuring Chinese adolescent beliefs and attitudes towards substance abuse.

    Fok MS, Tsang WY.

    J Clin Nurs. 2005 Sep;14(8):986-94.

    PMID:
    16102150
    [PubMed - indexed for MEDLINE]
    6.

    Reliability and factorial validity of the Observer Alexithymia Scale-Chinese translation.

    Yao S, Yi J, Zhu X, Haviland MG.

    Psychiatry Res. 2005 Mar 30;134(1):93-100.

    PMID:
    15808294
    [PubMed - indexed for MEDLINE]
    7.

    Can abuse deterrent formulations make a difference? Expectation and speculation.

    Budman SH, Grimes Serrano JM, Butler SF.

    Harm Reduct J. 2009 May 29;6:8.

    PMID:
    19480676
    [PubMed]
    Free PMC Article
    8.

    Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.

    Inciardi JA, Surratt HL, Cicero TJ, Beard RA.

    Pain Med. 2009 Apr;10(3):537-48.

    PMID:
    19416440
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Direct costs of opioid abuse in an insured population in the United States.

    White AG, Birnbaum HG, Mareva MN, Daher M, Vallow S, Schein J, Katz N.

    J Manag Care Pharm. 2005 Jul-Aug;11(6):469-79.

    PMID:
    15998164
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Multimethod alexithymia assessment in adolescents and young adults with a cannabis use disorder.

    Dorard G, Berthoz S, Haviland MG, Phan O, Corcos M, Bungener C.

    Compr Psychiatry. 2008 Nov-Dec;49(6):585-92. Epub 2008 Aug 23.

    PMID:
    18970907
    [PubMed - indexed for MEDLINE]
    11.

    Arthroscopic assessment of cartilage repair: a validation study of 2 scoring systems.

    Smith GD, Taylor J, Almqvist KF, Erggelet C, Knutsen G, Garcia Portabella M, Smith T, Richardson JB.

    Arthroscopy. 2005 Dec;21(12):1462-7.

    PMID:
    16376236
    [PubMed - indexed for MEDLINE]
    12.

    [The estimation of premorbid intelligence levels in French speakers].

    Mackinnon A, Mulligan R.

    Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43. French.

    PMID:
    15971638
    [PubMed - indexed for MEDLINE]
    13.

    Rating scales for dystonia: a multicenter assessment.

    Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T; Dystonia Study Group.

    Mov Disord. 2003 Mar;18(3):303-12.

    PMID:
    12621634
    [PubMed - indexed for MEDLINE]
    14.

    Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.

    Cicero TJ, Inciardi JA, Muñoz A.

    J Pain. 2005 Oct;6(10):662-72.

    PMID:
    16202959
    [PubMed - indexed for MEDLINE]
    15.

    Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

    Pain Pract. 2008 Jul-Aug;8(4):287-313. Epub 2008 May 23.

    PMID:
    18503626
    [PubMed - indexed for MEDLINE]
    16.

    Cross-cultural adaptation and psychometric validation of a Spanish version of the Quality of Life in Late-Stage Dementia Scale.

    Garre-Olmo J, Planas-Pujol X, López-Pousa S, Weiner MF, Turon-Estrada A, Juvinyà D, Ballester D, Vilalta-Franch J.

    Qual Life Res. 2010 Apr;19(3):445-53. Epub 2010 Feb 3.

    PMID:
    20127183
    [PubMed - indexed for MEDLINE]
    17.

    [Validation of the French version of the Body Shape Questionnaire].

    Rousseau A, Knotter A, Barbe P, Raich R, Chabrol H.

    Encephale. 2005 Mar-Apr;31(2):162-73. French.

    PMID:
    15959443
    [PubMed - indexed for MEDLINE]
    18.

    Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.

    Chiba R, Miyamoto Y, Kawakami N.

    Int J Nurs Stud. 2010 Mar;47(3):314-22. Epub 2009 Aug 12.

    PMID:
    19679304
    [PubMed - indexed for MEDLINE]
    19.

    Development of opioid formulations with limited diversion and abuse potential.

    Fudala PJ, Johnson RE.

    Drug Alcohol Depend. 2006 Jun;83 Suppl 1:S40-7. Epub 2006 Mar 24.

    PMID:
    16564141
    [PubMed - indexed for MEDLINE]
    20.

    Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.

    Larsson P.

    Swed Dent J Suppl. 2010;(204):11-98.

    PMID:
    20623943
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk